JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Fidelity Quality Factor ETF
FQAL
$1.46B
| $2.2M | ﹤0.01% |
33,879
+2,742
| +9% | +$171K |
|
|
VTYX
3777
DELISTED
Ventyx Biosciences
VTYX
| $2.2M | ﹤0.01% |
1,007,519
+20,236
| +2% | +$46.5K |
|
3778
Spruce Power Holding Corp
SPRU
$35.4M
| $2.2M | ﹤0.01% |
773,166
+161
| +0% | +$493 |
|
|
ONC
3779
BeOne Medicines Ltd
ONC
$39.3B
| $2.2M | ﹤0.01% |
9,780
-2,708
| -22% | -$487K |
|
3780
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.54B
| $2.19M | ﹤0.01% |
158,598
+113,068
| +248% | +$1.28M |
|
3781
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.38B
| $2.19M | ﹤0.01% |
22,852
+6,679
| +41% | +$612K |
|
3782
Grid Dynamics Holdings
GDYN
$629M
| $2.18M | ﹤0.01% |
155,759
-366,303
| -70% | -$4.73M |
|
|
INN
3783
Summit Hotel Properties
INN
$651M
| $2.18M | ﹤0.01% |
317,189
-792,862
| -71% | -$5.05M |
|
3784
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $2.17M | ﹤0.01% |
75,752
+55,919
| +282% | +$1.53M |
|
|
CNTA
3785
DELISTED
Centessa Pharmaceuticals
CNTA
| $2.17M | ﹤0.01% |
135,903
+129,335
| +1,969% | +$1.58M |
|
3786
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $2.17M | ﹤0.01% |
78,807
+11,218
| +17% | +$306K |
|
3787
Shenandoah Telecom
SHEN
$735M
| $2.17M | ﹤0.01% |
153,850
-64,885
| -30% | -$1.07M |
|
3788
Bank First Corp
BFC
$1.75B
| $2.16M | ﹤0.01% |
23,865
+13,502
| +130% | +$1.2M |
|
3789
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.87B
| $2.16M | ﹤0.01% |
88,807
+344
| +0.4% | +$8.29K |
|
3790
Olema Pharmaceuticals
OLMA
$930M
| $2.16M | ﹤0.01% |
181,032
+157,171
| +659% | +$2.01M |
|
3791
AdaptHealth
AHCO
$775M
| $2.15M | ﹤0.01% |
191,833
+81,097
| +73% | +$862K |
|
3792
Theravance Biopharma
TBPH
$881M
| $2.15M | ﹤0.01% |
266,879
+7,620
| +3% | +$66K |
|
3793
Washington Trust Bancorp
WASH
$767M
| $2.15M | ﹤0.01% |
66,737
+25,029
| +60% | +$765K |
|
|
FITB
3794
PUT
Fifth Third Bancorp
FITB
$52.7B
| $2.14M | ﹤0.01% |
+50,000
| New | +$2.03M |
|
3795
VanEck Biotech ETF
BBH
$424M
| $2.14M | ﹤0.01% |
12,072
-2,773
| -19% | -$492K |
|
3796
CALL
Zscaler
ZS
$29.7B
| $2.14M | ﹤0.01% |
+12,500
| New | +$2.28M |
|
|
3797
PUT
Zscaler
ZS
$29.7B
| $2.14M | ﹤0.01% |
+12,500
| New | +$2.28M |
|
3798
Northeast Bank
NBN
$1.15B
| $2.14M | ﹤0.01% |
27,699
+15,975
| +136% | +$1.08M |
|
3799
Under Armour Class C
UA
$2.26B
| $2.13M | ﹤0.01% |
255,219
-267,880
| -51% | -$1.92M |
|
3800
IDT Corp
IDT
$1.66B
| $2.13M | ﹤0.01% |
55,876
+5,417
| +11% | +$201K |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.